Abich Financial Wealth Management LLC Recursion Pharmaceuticals, Inc. Transaction History
Abich Financial Wealth Management LLC
- $44.5 Billion
- Q3 2024
A detailed history of Abich Financial Wealth Management LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 1,063 shares of RXRX stock, worth $7,409. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,063
Previous 292
264.04%
Holding current value
$7,409
Previous $2.19 Million
219.86%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
290Shares Held
239MCall Options Held
984KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$228 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$176 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$121 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$107 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.26B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...